CONMED Corp (CNMD) income statement
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$48.01−0.38 (-0.79%)
Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%
CONMED Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 57.6%
- Operating margin
- 9.9%
- Net margin
- 5.4%
- Return on equity, FY2025
- 4.7%
Financial strength
- Current ratio
- 1.49
- Debt to equity
- 0.77
- Debt to assets
- 35.4%
- Cash to current liabilities
- 10.5%
Valuation
- P/E ratio
- 19.8
- Price to sales
- 1.04
- Price to book
- 1.35
- Dividend yield
- 1.25%
See a number that looks wrong?